Reco Raises $55.0M to Expand Customer Review Platform

Atlar

Atlar is the AI-native treasury platform used by today's leading growth companies to manage cash, payments, forecasting, and liquidity in one place. Teams at Bandwidth, Lovable, Oyster, Trustly, Tide, GetYourGuide, Mangopay, and Zilch use Atlar to connect every bank and ERP they work with. That connectivity is built and owned by Atlar end to end — no third-party middleware — and now carries over €500B in annualized transaction volume across 100+ countries. Atlar's agents run on that data. Each morning they work out your cash position across every bank, entity, and currency and explain what moved. They brief you on payments before money leaves, track FX exposures as they build, and flag cash sitting idle at what it's costing you today. Agents run on your treasury policy and your team's existing permissions, and every action is logged. The result: thousands of hours of manual work removed, idle cash put to work, and errors cut at scale, typically live in under 90 days. Atlar is the top-rated TMS on G2 with a 5-star customer rating, a preferred partner of Oracle NetSuite, Citi, and J.P. Morgan, and backed by Index Ventures and General Catalyst. Headquartered in Stockholm, with offices in London, Berlin, and New York.

Asgard Therapeutics

Asgard Therapeutics is a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy. The company builds on ground-breaking and proprietary reprogramming technologies to develop gene therapy products designed to set in motion efficient and personalized immune responses. Backed by top investors, Asgard Therapeutics aims to establish a pipeline of off-the shelf cancer immunotherapies that trigger personalized anti-cancer immune responses for the benefit of cancer patients in need.